An appeals court ruling upholding a challenge to a deal by gene sequencing giant Illumina is a boost to the agency’s sweeping antitrust strategy.
© 2024 - USMAIL24.COM. All Rights Reserved.
An appeals court ruling upholding a challenge to a deal by gene sequencing giant Illumina is a boost to the agency’s sweeping antitrust strategy.